The Function and Potential Application of Extracellular Vesicle Derived Clara Cell Protein 16 in Gram-negative Bacterial Pneumonia
Description: PROJECT NARRATIVE Gram-negative (G-) bacterial-induced pneumonia is responsible for more than 30% of hospital-acquired pneumonia (HAP) and predominate in ventilator-associated pneumonia (VAP), which can trigger an explosive inflammatory response in the lung and cause alveolar edema, decreased lung compliance and ultimately, hypoxemia. In the current proposal, we identified Clara Cell Protein 16 (CC16) can be secreted in an extracellular vesicle (EV)-dependent manner and this EV-derived CC16 has a potential protective role against G- bacterial-induced lung injury (ALI). Thus, this research project will not only extend our knowledge on the role of CC16 in the pathogenesis of G- pneumonia but also explore a potential therapeutic strategy using aerosolized CC16-enriched EV to limit the progression of ALI.
Funding type: research
Funder scheme: R56
Start date: 2023-09-01
End date: 2025-08-31
Investigator: DUO ZHANG (lead)
Institution: University of Georgia
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 17
Funder award ID: R56HL163607
OpenAlex ID: G7998909050
